Article

baltimoresun.combaltimoresun.com on 2024-03-26 07:00

Maryland drug affordability board considers eight drugs for first cost review

The state's Prescription Drug Affordability Board is considering eight drugs for its first cost review process, including Ozempic, Biktarvy and others.

Related news